Drug
TD-6450 clinical trials
Also written TD-6450.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2014 | 2 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Theravance Biopharma (2) · Trek Therapeutics, PBC (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses TD-6450 is read from its arms, and is right about nine times in ten.
Testing it · 3
- TD-6450 MAD Study in HCV Infected SubjectsCompletedPhase 1Theravance BiopharmaNCT02116543Written as TD-6450
- TD-6450 SAD and MAD in Healthy SubjectsCompletedPhase 1Theravance BiopharmaNCT02022306Written as TD-6450
- A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus InfectionCompletedPhase 2Trek Therapeutics, PBCNCT02593162Written as TD-6450